Biotech entity
pharma is the sole category represented across all 1 tracked stories. Eli Lilly is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. They are better corroborated than the beat average, carrying 6 original sources each against 2.6 for the same window.
Last mentioned: Mar 19, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
pharma is the sole category represented across all 1 tracked stories. Eli Lilly is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. They are better corroborated than the beat average, carrying 6 original sources each against 2.6 for the same window. The 7 average consequence score is above the beat benchmark of 6 in the same window. University of Pittsburgh appears in 1 tracked Biotech story from March 19, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 23 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering University of Pittsburgh. Shared-story counts are live from our verified record — not editorial picks.
University of Pittsburgh researchers have identified a novel mechanism to restore leptin sensitivity, potentially overcoming the 'leptin resistance' that has long hindered weight loss treatments. This discovery could pave the way for a new class of obesity drugs that function independently of the currently dominant GLP-1 pathways.
University of Pittsburgh is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
